Related Experiment Video

Updated: Aug 8, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Management of heart failure patients in Poland

J Korewicki1, S Rywik, T Rywik

  • 1II Department of Valvular heart Disease, Stefan Cardinal Wyszynski, National Institute of Cardiology, Alpejska str.42, 04-828, Warszawa, Poland. jkorewicki@ikard.waw.pl

European Journal of Heart Failure
|April 18, 2002
PubMed

Insights

Heart failure care in Poland faces challenges due to limited cardiac procedures and inadequate pharmaceutical treatment, impacting patient outcomes. Improving cardiology standards requires increased financial investment in the State Health System.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Heart failure (HF) is projected to increase as a significant medical and sociological issue within the next decade.
  • Current cardiac procedures in Poland are half those in Western Europe, with long waiting times for interventions.
  • Existing diagnostic and pharmaceutical management for HF patients falls short of recommended standards.

Purpose of the Study:

  • To assess the current state of cardiology and cardiac surgery services for heart failure patients in Poland.
  • To identify deficiencies in diagnostic testing and pharmaceutical treatment protocols for heart failure.
  • To highlight the impact of financial resources on the quality of cardiological care.

Main Methods:

  • Review of current practices in diagnostic testing (ECG, chest X-ray, biochemical evaluation, echocardiography, exercise testing, Holter monitoring).
  • Analysis of pharmaceutical treatment patterns, including ACE inhibitor and beta-blocker prescription rates and dosages.
  • Comparison of procedure availability and waiting times with Western European standards.

Main Results:

  • Significant disparities exist in the availability of cardiological and cardiac surgery procedures compared to Western Europe.
  • Patients face substantial waiting periods for both procedures and advanced diagnostic tests.
  • Inadequate prescription rates and dosages of key medications like ACE inhibitors and beta-blockers were observed.
  • The study underscores a critical gap in adherence to established clinical guidelines for HF management.

Conclusions:

  • The current standard of cardiological care for heart failure in Poland is insufficient, characterized by limited access to procedures and suboptimal medical treatment.
  • Addressing the growing burden of heart failure necessitates substantial improvements in healthcare funding and resource allocation.
  • Enhancing the quality of care for heart failure patients is contingent upon increased financial investment in the State Health System.

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...